Linden Thomas Advisory Services »

Royalty Pharma shares owned by Linden Thomas Advisory Services

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Linden Thomas Advisory Services from 13F filings

Historical chart of Linden Thomas Advisory Services investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Linden Thomas Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Linden Thomas Advisory Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 34k 30.37
2023-12-31 $870k 31k 28.09
2023-09-30 $782k 29k 27.14

More positions owned by Linden Thomas Advisory Services

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
salesforce (CRM)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Chemed Corp Com Stk (CHE)
Netflix (NFLX)
Lam Research Corporation (LRCX)
Intuit (INTU)
Gartner (IT)
Adobe Systems Incorporated (ADBE)
Lockheed Martin Corporation (LMT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Linden Thomas Advisory Services

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma